Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$646K Sell
816
-30
-4% -$20K ﹤0.01% 1085
2026
Q1
$461K Sell
846
-7
-0.8% -$2.85K ﹤0.01% 948
2025
Q4
$267K Sell
853
-136
-14% -$43.2K ﹤0.01% 1126
2025
Q3
$267K Buy
989
+69
+8% +$15.8K ﹤0.01% 1092
2025
Q2
$203K Buy
+920
New +$166K ﹤0.01% 1148
2025
Q1
Sell
-10,552
Closed -$1.45M 1084
2024
Q4
$1.45M Buy
10,552
+133
+1% +$18.3K 0.01% 534
2024
Q3
$1.06M Buy
10,419
+134
+1% +$10.6K 0.01% 619
2024
Q2
$752K Buy
10,285
+431
+4% +$28.2K 0.01% 676
2024
Q1
$498K Buy
+9,854
New +$462K 0.01% 727

Other funds holding AGX

Savant Capital's AGX Position: Q2 2026 in Review

Savant Capital reduced its Argan (AGX) stake by 3.5% in Q2 2026, selling an estimated $20K and leaving 816 shares worth $646K. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Savant Capital first reported a position in AGX in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.45M in Q4 2024. 564 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Savant Capital held 816 shares of Argan worth $646K as of Q2 2026.
  • Savant Capital sold 30 Argan shares in Q2 2026, an estimated $20K.
  • Argan made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1085 holding.
  • Savant Capital first reported a position in Argan in Q1 2024 and has held it in 9 quarters since.
  • Savant Capital's Argan position peaked at $1.45M in Q4 2024.
  • 564 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.